Bulletproof Helmet Market to Reach $2.2 billion, Globally, by 2034 at 5.7% CAGR: Allied Market Research
Increase in global defense expenditure, rise in demand for personal protective equipment (PPE) among military and law enforcement, and growth in the threat of asymmetric... Read more.
ESMO releases first-ever guidance for safe use of AI Language Models in cancer care
The ELCAP guidance sets standards for responsible AI use in oncology, protecting patients and supporting clinicians LUGANO, Switzerland and BERLIN, Oct. 20, 2025... Read more.
CoinLander Launches RWA Platform, Unlocking Stable Returns from Tokenized Real Estate Mortgages
Platform Democratizes Access to Real-World Asset (RWA) Investments, Merging Tangible Security with Blockchain Efficiency ROAD TOWN, British Virgin Islands, Oct.... Read more.
AP Pension selects Cognizant for BPO and RPA-services as part of multi-year transformation
Through the new collaboration, Cognizant will deliver business process outsourcing and RPA-services to AP Pension with the aim to strengthen capacity, improve efficiency... Read more.
Report shows best locations for fusion reactor in the Nordics
ESPOO, Finland, Oct. 20, 2025 /PRNewswire/ — As the global fusion race accelerates, Novatron Fusion Group (NFG) – the only private fusion energy company... Read more.
Liquid Wind and Umeå Energi Finalise Agreements to Commercialise eFuel Facility in Umeå, Sweden
GOTHENBURG, Sweden, Oct. 20, 2025 /PRNewswire/ — Liquid Wind and Umeå Energi have signed all necessary agreements to commercialise a large-scale eFuel production... Read more.
Live from ESMO | Hengrui Debuts Exhibition Booth with Landmark Data Showcasing Pharma’s Emerging Innovation Power
BERLIN, Oct. 20, 2025 /PRNewswire/ — From October 17 to 21, the European Society for Medical Oncology (ESMO) Annual Congress convened in Berlin, bringing together... Read more.
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
LONDON, Oct. 20, 2025 /PRNewswire/ — Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced today that it has successfully completed the acquisition... Read more.
MILESEEY GenePro G1 Named to TIME’s “The Best Inventions of 2025: Special Mentions”
The first “GPS + Laser” hybrid rangefinder redefining how golfers see and play the game. CITY OF INDUSTRY, Calif., Oct. 20, 2025 /PRNewswire/ —... Read more.
Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that at the 2025 European... Read more.